Latest News - CRSTodayEurope

Friday, March 24, 2017 | Product Releases

Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with Restasis Multidose

Aptar Pharma’s innovative and patented preservative-free multidose ophthalmic squeeze dispenser is available for patients in the US prescription market for the first time with Allergan’s&n…

Read the full story

Friday, March 24, 2017 | Medical Studies

How Blind People's Brains Rewire to Improve Other Senses

A new study delves into the neurological changes in people with blindness. It demonstrates that losing one's sight before the age of 3 causes long-term alterations and subsequent enhancements to t…

Read the full story

Friday, March 24, 2017 | Medical Studies

Repeated Bevacizumab Injections Tied to Higher Glaucoma Surgery Risk

Seven or more intravitreous bevacizumab injections in a year is associated with a higher risk of glaucoma surgery, researchers in Canada say. "The advent of intravitreous anti-vascular endothelia…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance

Icare USA Receives FDA Clearance for Icare HOME Tonometer

Icare USA announced that the Icare HOME tonometer has been cleared by the FDA and is now available for use in the United States. The Icare HOME device, which received CE Marking in 2014, allows eye ca…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance, Alcon Laboratories

Alcon Receives FDA Approval for AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus

Alcon has received approval from the FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus, designed for patients undergoing cataract surgery who choose to address their astigmatism…

Read the full story

Wednesday, March 22, 2017 | Management/Leadership, Shire

Joe Boyd Joins Shire as Director, Market Development, Ophthalmics

Shire has announced that Joe Boyd has joined the Ophthalmics team as Director, Market Development. In this role, Mr. Boyd will work closely with thought leaders, key opinion leaders, and teaching inst…

Read the full story

Wednesday, March 22, 2017 | Product Releases, Allergan

Allergan Announces Availability of Restasis Multidose (Cyclosporine Ophthalmic Emulsion) 0.05%

Allergan announced the availability of Restasis Multidose, which is the same preservative-free Restasis formulation, but now offered in a multidose bottle. Restasis Multidose is the first and only FDA…

Read the full story

Wednesday, March 22, 2017 | Glaucoma, Partnerships, Ora

AXIM Biotech Retains Contract Research Organization ORA to Manage Glaucoma & Dry Eye Indications Product Development and Clinical Trials

Axim Biotechnologies is retaining the services from contract research organization Ora to run the company’s upcoming product development and clinical trials for the treatment of glaucoma and dry…

Read the full story

Wednesday, March 22, 2017 | Medical Studies, Ocular Therapeutix

New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix’ Dextenza Following Cataract Surgery

Ocular Therapeutix announced positive results of a patient experience study of Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use. The study, published in Patient Preference and Adhe…

Read the full story

Wednesday, March 22, 2017 | Miscellaneous, Prevent Blindness

April Declared Women’s Eye Health and Safety Awareness Month

More women than men have eye disease, including age-related macular degeneration (AMD), cataracts, and glaucoma. According to the Prevent Blindness study, "The Future of Vision: Forecasting the P…

Read the full story

Wednesday, March 22, 2017 | Glaucoma, Medical Studies

Body-tilt Test Helps Predict Optic Nerve Tissue Loss in Glaucoma

Changes in pattern electroretinogram (PERG) and other measures associated with head-down-body-tilt (HDT) position predict future loss of optic nerve tissue in individuals at risk for glaucoma, accordi…

Read the full story

Wednesday, March 22, 2017 | Clinical Trials, Management/Leadership

ClarVista Medical Completes Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, a privately-held ophthalmic device company developing the Harmoni Modular IOL System, a novel IOL used to restore vision after cataract surgery, announced that several feasibility t…

Read the full story

Wednesday, March 22, 2017 | Miscellaneous

Physician Who Tricked Patients Into Surgery Gets 10 Years

Ophthalmologist David Ming Pon, MD, MPH, was sentenced last week in a federal district court in Jacksonville, Florida, to 10 years in prison for bilking Medicare out of nearly $10 million. One could c…

Read the full story

Tuesday, March 21, 2017 | Health Care, Prevent Blindness

Prevent Blindness Urges Secretary Price to Prioritize Eye and Vision Health

In a letter to the newly confirmed US Department of Health and Human Services Secretary Thomas Price, Prevent Blindness urged the secretary to prioritize adult and children’s vision health in co…

Read the full story

Tuesday, March 21, 2017 | Medical Studies

"Living with Sjögren's" Survey Demonstrates Impact Sjögren’s Has on Ability to Function at Home and At Work

For the overwhelming majority of patients living with Sjögren’s, an autoimmune disorder affecting more than 4 million Americans (90% of whom are women), every day is a challenge in coping w…

Read the full story
Load More